PDL1 Detection Set
-
- Target Alle PD-L1 Produkte
- PD-L1 (CD274 (PD-L1))
- Fragment
- single-domain Antibody (sdAb)
- Bindungsspezifität
- AA 19-239
- Reaktivität
- Human
-
Wirt
- Llama
- Klonalität
- Monoklonal
- Applikation
- ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
- Produktmerkmale
- Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2. PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells. This suggests that PD-L1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts.
- Aufreinigung
- PD-L1 Antibodies are affinity chromatography purified via Nickel column.
- Bestandteile
-
PD-L1 Antibody [F1A12]
PD-L1 Antibody [F1C9]
PD-L1 Antibody [F6A9]
PD-L1 Antibody [F2G2] - Immunogen
- PD-L1 antibodies were raised against a recombinant protein corresponding to amino acids 19 - 239 of human PD-L1.
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PD-L1 Antibodies are supplied in PBS containing 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
- Target
- PD-L1 (CD274 (PD-L1))
- Andere Bezeichnung
- PDL1 (PD-L1 Produkte)
-